Cargando…
“Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants’ full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350979/ https://www.ncbi.nlm.nih.gov/pubmed/30695047 http://dx.doi.org/10.1371/journal.pone.0211338 |
_version_ | 1783390522507788288 |
---|---|
author | Nakada, Haruka Yoshida, Sachie Muto, Kaori |
author_facet | Nakada, Haruka Yoshida, Sachie Muto, Kaori |
author_sort | Nakada, Haruka |
collection | PubMed |
description | Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants’ full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision of whether to give consent. The objective of this study, therefore, is to analyze patients’ decision-making process when participating in clinical trials. We conduct an internet survey (n = 2,045) and interview data analysis (n = 40) with patients and categorize respondents into three types of participants: active, passive, and non-participation. Our results show that patients often make informal and quick decisions before medical staff provide them with relevant information during the informed consent process. For example, 55.9% of patients received initial information on clinical trials from an online article or web advertising, and 54.5% consulted no one about whether to participate in the clinical trial before making a decision. Only 20.7% of respondents subjectively spent time making the decision whether to participate; 43.0% of patients who said that they “spent time” coming to a decision took four or more days to reach a decision, while 8.3% of people who “did not spend time” making a decision took this among of time. Based on these results, we were able to break patients’ decision-making process into four steps: first contact, informal decision making, relevant information, and formal decision making. Our results show that patients are most likely to make a decision based on the first information they receive on the clinical trial, whatever the source. To this end, having a list of questions for potential participants to ask researchers would be useful in helping better collecting information of clinical trials. In addition, research teams should give patients more than four days to decide between providing them with relevant information and obtaining written consent, even if the patient seems to make a quick decision. |
format | Online Article Text |
id | pubmed-6350979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63509792019-02-15 “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials Nakada, Haruka Yoshida, Sachie Muto, Kaori PLoS One Research Article Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants’ full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision of whether to give consent. The objective of this study, therefore, is to analyze patients’ decision-making process when participating in clinical trials. We conduct an internet survey (n = 2,045) and interview data analysis (n = 40) with patients and categorize respondents into three types of participants: active, passive, and non-participation. Our results show that patients often make informal and quick decisions before medical staff provide them with relevant information during the informed consent process. For example, 55.9% of patients received initial information on clinical trials from an online article or web advertising, and 54.5% consulted no one about whether to participate in the clinical trial before making a decision. Only 20.7% of respondents subjectively spent time making the decision whether to participate; 43.0% of patients who said that they “spent time” coming to a decision took four or more days to reach a decision, while 8.3% of people who “did not spend time” making a decision took this among of time. Based on these results, we were able to break patients’ decision-making process into four steps: first contact, informal decision making, relevant information, and formal decision making. Our results show that patients are most likely to make a decision based on the first information they receive on the clinical trial, whatever the source. To this end, having a list of questions for potential participants to ask researchers would be useful in helping better collecting information of clinical trials. In addition, research teams should give patients more than four days to decide between providing them with relevant information and obtaining written consent, even if the patient seems to make a quick decision. Public Library of Science 2019-01-29 /pmc/articles/PMC6350979/ /pubmed/30695047 http://dx.doi.org/10.1371/journal.pone.0211338 Text en © 2019 Nakada et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Nakada, Haruka Yoshida, Sachie Muto, Kaori “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials |
title | “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials |
title_full | “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials |
title_fullStr | “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials |
title_full_unstemmed | “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials |
title_short | “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials |
title_sort | “tell me what you suggest, and let’s do that, doctor”: patient deliberation time during informal decision-making in clinical trials |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350979/ https://www.ncbi.nlm.nih.gov/pubmed/30695047 http://dx.doi.org/10.1371/journal.pone.0211338 |
work_keys_str_mv | AT nakadaharuka tellmewhatyousuggestandletsdothatdoctorpatientdeliberationtimeduringinformaldecisionmakinginclinicaltrials AT yoshidasachie tellmewhatyousuggestandletsdothatdoctorpatientdeliberationtimeduringinformaldecisionmakinginclinicaltrials AT mutokaori tellmewhatyousuggestandletsdothatdoctorpatientdeliberationtimeduringinformaldecisionmakinginclinicaltrials |